Profile
Ambarish Shah is Chief Technology Officer at DiaMedica Therapeutics, Inc. since 2023.
Formerly, Dr. Shah was Executive Director & Head-Drug Product Development at Bristol Myers Squibb Co. and Vice President & Head-Global Vaccines Development at Csl Seqirus.
Education includes a doctorate from Mercer University, a graduate degree from Duquesne University School of Law, and an undergraduate degree from the University of Mumbai.
Ambarish Shah active positions
| Companies | Position | Start |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2023-09-11 |
Former positions of Ambarish Shah
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director/Board Member | - |
Csl Seqirus | Corporate Officer/Principal | - |
Training of Ambarish Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DiaMedica Therapeutics, Inc.
DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duquesne University School of Law
Duquesne University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Csl Seqirus | Health Technology |
- Stock Market
- Insiders
- Ambarish Shah
















